Ligand Pharmaceuticals LGND
NASDAQ LGND
$312.37 +2.01 (+0.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Total Non-Current Liabilities (2010 - 2026)

Updated

Ligand Pharmaceuticals' Total Non-Current Liabilities was $1.2 billion in Q2 2026, compared with $106.92 million a year earlier and up 132.0% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Ligand Pharmaceuticals came in at $526.8 million, up 549.0% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $81.17 million in FY2024 (+38.6%), $58.55 million in FY2023 (-57.4%), $137.43 million in FY2022 (-69.8%) and $454.68 million in FY2021 (-26.9%).
  • The Q2 2026 figure marks the highest quarterly Total Non-Current Liabilities since Q3 2018.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q4 2025 (growth of 549.0%); the worst was Q3 2023 (a decline of 72.8%).
  • Per Business Quant data, LGND's Total Non-Current Liabilities in the three quarters before Q2 2026 was $517.67 million (Q1 2026), $526.8 million (Q4 2025) and $506.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Ligand Pharmaceuticals 6.22 Bn 2.69 Bn - 1.20 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Bn
Mar 31, 2026 517.67 Mn
Dec 31, 2025 526.80 Mn
Sep 30, 2025 506.69 Mn
Jun 30, 2025 106.92 Mn
Mar 31, 2025 95.59 Mn
Dec 31, 2024 81.17 Mn
Sep 30, 2024 83.81 Mn
Jun 30, 2024 61.86 Mn
Mar 31, 2024 79.57 Mn
Dec 31, 2023 58.55 Mn
Sep 30, 2023 57.66 Mn
Jun 30, 2023 71.55 Mn
Mar 31, 2023 142.90 Mn
Dec 31, 2022 137.43 Mn
Sep 30, 2022 212.36 Mn
Jun 30, 2022 252.00 Mn
Mar 31, 2022 282.80 Mn
Dec 31, 2021 454.68 Mn
Sep 30, 2021 434.46 Mn
API Access

Ligand Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=LGND&period=max&api_key=YOUR_API_KEY